Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study
dc.contributor.author | Váradi, Melinda | |
dc.contributor.author | Horváth, Orsolya | |
dc.contributor.author | Módos, Orsolya | |
dc.contributor.author | Fazekas, Tamás | |
dc.contributor.author | Grunewald, Camilla M. | |
dc.contributor.author | Niegisch, Günter | |
dc.contributor.author | Krafft, Ulrich | |
dc.contributor.author | Grünwald, Viktor | |
dc.contributor.author | Hadaschik, Boris | |
dc.contributor.author | Oláh, Csilla | |
dc.contributor.author | Maráz, Anikó | |
dc.contributor.author | Furka, Andrea | |
dc.contributor.author | Szűcs, Miklós | |
dc.contributor.author | Nyirády, Péter | |
dc.contributor.author | Szarvas, Tibor | |
dc.date.accessioned | 2023-10-11T08:06:44Z | |
dc.date.available | 2023-10-11T08:06:44Z | |
dc.date.issued | 2023 | |
dc.date.oa | 2023-11-10 | |
dc.date.pasync | 2023-11-11T00:06:35Z | |
dc.date.updated | 2023-10-11T08:06:44Z | |
dc.description.corrector | kzs | |
dc.identifier.citation | Scientific Reports. -13 (2023), p. 1-11. -Sci. Rep. - 2045-2322 | |
dc.identifier.doi | http://dx.doi.org/10.1038/s41598-023-44103-9 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM115283 | |
dc.identifier.scopus | 85174198606 | |
dc.identifier.uri | https://hdl.handle.net/2437/359681 | |
dc.language | eng | |
dc.rights.access | open access journal | |
dc.rights.access | open access article | |
dc.rights.owner | Nature Publishing Group | |
dc.rights.owner | szerző | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Klinikai orvostudományok | |
dc.title | Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |